Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$374M |
| 2 |
AT&T
T
|
+$293M |
| 3 |
NVIDIA
NVDA
|
+$291M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$283M |
| 5 |
Williams Companies
WMB
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.09B |
| 2 |
Lam Research
LRCX
|
+$351M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$330M |
| 4 |
Apple
AAPL
|
+$328M |
| 5 |
Boeing
BA
|
+$292M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.97% |
| 3 | Financials | 6.13% |
| 4 | Consumer Discretionary | 5.62% |
| 5 | Industrials | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2826
PUT
Arthur J. Gallagher & Co
AJG
$63.6B
| $3.69M | ﹤0.01% |
19,300
-7,600
| -28% | -$1.44M |
|
2827
PUT
Teva Pharmaceuticals
TEVA
$40.1B
| $3.69M | ﹤0.01% |
417,200
+119,100
| +40% | +$1.18M |
|
|
FITB
2828
CALL
Fifth Third Bancorp
FITB
$52.4B
| $3.69M | ﹤0.01% |
138,500
-11,300
| -8% | -$375K |
|
2829
CALL
Ares Capital
ARCC
$14.1B
| $3.67M | ﹤0.01% |
+201,000
| New | +$3.8M |
|
2830
Unitil
UTL
$964M
| $3.67M | ﹤0.01% |
+64,355
| New | +$3.44M |
|
2831
CALL
Pinterest
PINS
$14.3B
| $3.67M | ﹤0.01% |
134,500
-183,300
| -58% | -$4.75M |
|
2832
PDS Biotechnology
PDSB
$40.3M
| $3.67M | ﹤0.01% |
596,272
+144,936
| +32% | +$1.19M |
|
2833
Vanguard Total World Stock ETF
VT
$79.4B
| $3.67M | ﹤0.01% |
+39,821
| New | +$3.61M |
|
2834
PUT
Ralph Lauren
RL
$22.5B
| $3.66M | ﹤0.01% |
31,400
+21,800
| +227% | +$2.57M |
|
|
CFFS
2835
DELISTED
CF Acquisition Corp. VII Class A Common Stock
CFFS
| $3.65M | ﹤0.01% |
353,000
+500
| +0.1% | +$5.12K |
|
2836
CALL
Spotify
SPOT
$98.3B
| $3.65M | ﹤0.01% |
27,300
+1,500
| +6% | +$172K |
|
2837
CALL
Raymond James Financial
RJF
$34.3B
| $3.64M | ﹤0.01% |
+39,000
| New | +$4.13M |
|
2838
CALL
Stellantis
STLA
$22.1B
| $3.64M | ﹤0.01% |
+200,000
| New | +$3.34M |
|
|
CTIC
2839
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
| $3.64M | ﹤0.01% |
866,152
-3,896,617
| -82% | -$20.2M |
|
2840
CALL
Tenet Healthcare
THC
$20.4B
| $3.64M | ﹤0.01% |
61,200
-83,400
| -58% | -$4.64M |
|
2841
American Vanguard Corp
AVD
$71.2M
| $3.63M | ﹤0.01% |
166,149
+65,423
| +65% | +$1.41M |
|
2842
Xponential Fitness
XPOF
$280M
| $3.63M | ﹤0.01% |
119,562
-321,275
| -73% | -$8.5M |
|
2843
PUT
Take-Two Interactive
TTWO
$44.9B
| $3.63M | ﹤0.01% |
30,400
-6,300
| -17% | -$703K |
|
|
RVNC
2844
DELISTED
Revance Therapeutics, Inc.
RVNC
| $3.63M | ﹤0.01% |
112,567
-385,262
| -77% | -$12M |
|
2845
PUT
Synchrony
SYF
$25.7B
| $3.62M | ﹤0.01% |
124,500
+79,400
| +176% | +$2.67M |
|
|
ARTE
2846
DELISTED
Artemis Strategic Investment Corporation Class A Common Stock
ARTE
| $3.62M | ﹤0.01% |
350,000
-30,422
| -8% | -$313K |
|
2847
Ooma
OOMA
$592M
| $3.62M | ﹤0.01% |
289,178
+122,251
| +73% | +$1.64M |
|
2848
CALL
Welltower
WELL
$167B
| $3.61M | ﹤0.01% |
50,400
+31,800
| +171% | +$2.31M |
|
2849
Jakks Pacific
JAKK
$298M
| $3.59M | ﹤0.01% |
207,765
+44,831
| +28% | +$840K |
|
2850
Dover
DOV
$28.3B
| $3.59M | ﹤0.01% |
23,638
-496,750
| -95% | -$72.9M |
|
Similar funds
Millennium Management's Q1 2023 Portfolio in Review
As of Q1 2023, Millennium Management held 7,511 positions worth $174B, down 3.5% from $181B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Millennium Management withdrew a net $18.1B in Q1 2023, closing 1,210 positions and reducing 2,570 holdings. Its most notable exit was Apollo Global Management, an estimated $112M position sold in full.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.2% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Millennium Management opened a new position in Warner Bros worth $96.9M.
- Millennium Management's largest Q1 2023 buy was Warner Bros: 6,417,147 shares worth $96.9M.
- Millennium Management added most to Linde in Q1 2023, an estimated $374M increase.
- Millennium Management's biggest Q1 2023 reduction was Invesco QQQ Trust, cutting an estimated $1.09B.
- Millennium Management fully exited Apollo Global Management in Q1 2023, selling an estimated $112M.
- Millennium Management's ten largest holdings make up 25% of its $174B portfolio in Q1 2023.
- Millennium Management opened 988 new positions and closed 1,210 in Q1 2023.
- Millennium Management's portfolio value fell 3.5% quarter-over-quarter to $174B.
Based on Millennium Management's 13F filing for Q1 2023, filed 15 May 2023.